KELLY DUDLEY: Open Payments
NPI 1053781492 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 12 payments from 6 companies in 2025. Trend: 2023 $477 · 2024 $211 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $111 |
| GENZYME CORPORATION | 2 | $46 |
| Grifols USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Verona Pharma, Inc. | 1 | $32 |
Products named: FASENRA, DUPIXENT, Prolastin-C Liquid, NUCALA, Ohtuvayre.
Industry payments across ME — which companies pay providers there.
